In the latest trading session, 0.47 million NKGen Biotech Inc (NASDAQ:NKGN) shares changed hands as the company’s beta touched 0.75. With the company’s most recent per share price at $0.46 changing hands around $0.02 or 4.39% at last look, the market valuation stands at $16.32M. NKGN’s current price is a discount, trading about -782.61% off its 52-week high of $4.06. The share price had its 52-week low at $0.20, which suggests the last value was 56.52% up since then. When we look at NKGen Biotech Inc’s average trading volume, we note the 10-day average is 1.33 million shares, with the 3-month average coming to 1.33 million.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

Instantly NKGN is in green as seen in intraday trades today. With action 26.36%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -83.30%, with the 5-day performance at 26.36% in the green. However, in the 30-day time frame, NKGen Biotech Inc (NASDAQ:NKGN) is 71.86% up. Looking at the short shares, we see there were 0.69 million shares sold at short interest cover period of 0.28 days.

NKGN Dividends

NKGen Biotech Inc is expected to release its next quarterly earnings report in January.

NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 42.32% of NKGen Biotech Inc shares while 12.19% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 21.14%.

Among Mutual Funds, the top two as of Sep 30, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 68.97 shares estimated at $31504.0 under it, the former controlled 0.20% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.15% of the shares, roughly 53.8 shares worth around $24577.0.